Detalhe da pesquisa
1.
Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
Hepatol Res
; 53(1): 51-60, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136893
2.
Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
Hepatol Res
; 52(3): 235-246, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861090
3.
Relationship between serum vitamin D level and sarcopenia in chronic liver disease.
Hepatol Res
; 50(5): 588-597, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914479
4.
Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization.
Hepatol Res
; 50(11): 1244-1254, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822521
5.
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
J Gastroenterol Hepatol
; 35(7): 1229-1237, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881554
6.
Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.
J Viral Hepat
; 26(11): 1266-1275, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31278795
7.
Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.
Hepatol Res
; 49(2): 125-135, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307682
8.
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan.
Hepatol Res
; 49(4): 369-376, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485638
9.
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.
J Gastroenterol Hepatol
; 34(2): 364-369, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30144366
10.
Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease.
Hepatol Res
; 48(7): 549-555, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29316062
11.
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein.
Hepatol Res
; 48(6): 424-432, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29274190
12.
Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
J Gastroenterol Hepatol
; 33(6): 1256-1263, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29215154
13.
Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease.
Hepatol Res
; 47(11): 1165-1173, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28225572
14.
Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants.
Hepatol Res
; 47(7): 641-649, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27487797
15.
Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C.
Hepatol Res
; 47(13): 1429-1437, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28457003
16.
Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.
Hepatol Res
; 46(5): 450-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26289410
17.
Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.
Int J Clin Oncol
; 21(4): 676-683, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26701173
18.
Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C.
J Med Virol
; 87(11): 1904-12, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25964133
19.
Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients.
BMC Infect Dis
; 15: 344, 2015 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26286329
20.
α-Fetoprotein is a surrogate marker for predicting treatment failure in telaprevir-based triple combination therapy for genotype 1b chronic hepatitis C Japanese patients with the IL28B minor genotype.
J Med Virol
; 86(3): 461-72, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24166425